Spago Nanomedical develops nanomaterials for improved cancer diagnostics and treatment
Optimizing cancer diagnostics and treatment
Spago Nanomedical develops nanomedical products for cancer diagnostics and treatment. The company’s main activities are focused on developing SpagoPix, a nanomedical contrast agent for MRI, and the therapeutic development project Tumorad, for tumor selective radionuclide treatment.
